Unrelated Donor Peripheral Blood Stem Cell (PBSC) Transplantation Using Nonmyeloablative Conditioning and Mycophenolate Mofetil (MMF) TID Results in High Engraftment Rates.
Michael B. Maris(Colorado Blood Cancer Institute), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Dietger Niederwieser(Leipzig University of Applied Sciences), Thomas R. Chauncey(City Of Hope National Medical Center), Ann E. Woolfrey(University of Washington), Amelia Langston(CancerCare Manitoba), Barry E. Storer(City Of Hope National Medical Center), Richard T. Maziarz(Oregon Health & Science University), Mike A. Pulsipher(Primary Children's Hospital), Brenda M. Sandmaier(University of Washington), Peter A. McSweeney(Mesoblast (United States)), E.D. Agura, Karl G. Blume(City Of Hope National Medical Center), Michelle Little(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Judith A. Shizuru(Stanford University), James C. Wade(Medizinische Hochschule Hannover), David G. Maloney(Fred Hutch Cancer Center)
Cited by 7
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2014|2.7k